Ailurus Biotechnology Co., Ltd is the world's first biocomputer company. We use synthetic biological systems for experimental testing and information processing, instead of traditional manual experiment and computer simulation, and build a set of design and programming organisms "operating system" on this basis. We aim to make biotech as efficient and accessible as the IT industry, providing tools and platforms for life science research and biological products development to dramatically improve efficiency and iteration.
We currently have a headquarters in Shenzhen, a production base in Suzhou, overseas offices in North America and Europe, and will set up a research and development laboratory in Beijing in early 2022. At present, we have received several rounds of investment from domestic first-line institutions.